The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into reports of possible side effects, including heart problems, neurological issues and even death.
💢 https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-and-cdc
💢 https://globalnews.ca/news/11177231/chikungunya-older-adults-travel-vaccine-canada/
💢 https://www.ndtv.com/health/avoid-chikungunya-vaccine-if-youre-over-60-say-us-health
💢 https://www.ema.europa.eu/en/news/ema-starts-review-ixchiq-live-attenuated-chikungunya-vaccine
💢 https://insights.citeline.com/pink-sheet/drug-safety/safety-review-prompts-ema-to-suspend-ixchiq- 💢 Archive: https://archive.is/XQmtb https://archive.is/ULrca
No comments:
Post a Comment